Identification of aldehyde oxidase as an enzyme in metabolism of zoniporide
Aldehyde oxidases are molybdoflavoenzymes present in cytosolic compartment with broad substrate specificity, oxidizing different types of aldehydes, and heterocyclic rings has attracted increased interest in recent years. The physiological function of aldehyde oxidases is largely unknown, although the enzymes play an important role in the metabolism of numerous compounds of medicinal and toxicological interest, as they oxidize a wide range of aldehydes and heterocyclic compounds Aldehyde oxidase. This unit provides methods for identification and confirmation of AO as metabolic pathways that are AO substrate as wel as the effect of different protein (Human S9 fractions) concentration on different concentrations of zoniporide. The peak at 3.29 min is Metabolized zoniporide while the peak at m/z 337 (RT = 3.22 min) suggests an addition of 16 amu to zoniporide. The maximum formation of metabolite shown up to 90 min in both protein concentrations respectively, further 90 min it decreases rapidly.
Brandänge S and Lindblom L (1979) The enzyme "aldehyde oxidase" is an iminium oxidase. Reaction with nicotine delta 1'(5') iminium ion. Biochem Biophys Res Commun 91:991-996.
Barr JT and Jones JP (2011) Inhibition of human liver aldehyde oxidase: implications for Potential drug-drug interactions. Drug Metab Dispos 39:2381–2386 Pryde DC, Dalvie D, Hu Q, Jones P, Obach RS, and Tran TD (2010) Aldehyde oxidase: an enzyme of emerging importance in drug discovery. J Med Chem 53:8441– 8460
Hutzler J, Obach R, Dalvie D, and Zientek M(2013) Strategies for a comprehensive understanding of metabolism by aldehyde oxidase. Expert Opin Drug Metab Toxicol 9:153-168.
Obach RS (2004) Potent inhibition of human liver aldehyde oxidase by raloxifene. Drug Metab Dispos 32:89 –97
Dalvie, D. and Zientek, M. 2015. Metabolism of Xenobiotics by Aldehyde Oxidase. Curr. Protoc. Toxicol. 63:4.41.1-4.41.13.
Houston, J.B. and Galetin, A. 2008. Methods for predicting in vivo pharmacokinetics using data from in vitro assays. Curr. Drug Metab. 9:940- 951.
Hutzler, J.M., Obach, R.S., Dalvie, D., and Zientek, M.A. 2013. Strategies for a comprehensive understanding of metabolism by aldehyde oxidase. Expert Opin. Drug Metab. Toxicol. 9:153-168.
Hutzler, J.M., Yang, Y.S., Brown, C., Heyward, S., and Moeller, T. 2014. Aldehyde oxidase activity in donor-matched fresh and cryopreserved human hepatocytes and assessment of variability in 75 donors. Drug Metab. Dispos. 42:1090- 1097.
Hutzler, J.M., Yang, Y.S., Albaugh, D., Fullenwider, C.L., Schmenk, J., and Fisher, M.B. 2012. Characterization of aldehyde oxidase enzyme activity in cryopreserved human hepatocytes. Drug Metab. Dispos. 40:267-275.
Johnson, C., Stubley-Beedham, C., and Stell, J.G. 1985. Hydralazine: A potent inhibitor of aldehyde oxidase activity in vitro and in vivo. Biochem. Pharmacol. 34:4251-4256.
Kitamura, S., Sugihara, K., and Ohta, S. 2006. Drug-metabolizing ability of molybdenum hydroxylases. Metab. Pharmacokinet. 21:83-98.
Obach, R.S. 1999. Prediction of human clearance of twenty-nine drugs from hepatic microsomal intrinsic clearance data: An examination of in vitro half-life approach and nonspecific binding to microsomes. Drug Metab. Dispos. 27:1350- 1359.
Obach, R.S. 2004. Potent inhibition of human liver aldehyde oxidase by raloxifene. Drug Metab. Dispos. 32:89-97.
Obach, R.S., Huynh, P., Allen, M.C., and Beedham, C. 2004. Human liver aldehyde oxidase: Inhibition by 239 drugs. Br. J. Clin Pharmacol. 44:7-19.
Pryde, D.C., Dalvie, D., Hu, Q., Jones, P., Obach, R.S., and Tran, T.D. 2010. Aldehyde oxidase: An enzyme of emerging importance in drug discovery. J. Med. Chem. 53:8441-8460.
Strelevitz, T.J., Orozco, C.C., and Obach, R.S. 2012. Hydralazine as a selective probe inactivator of aldehyde oxidase in human hepatocytes: Estimation of the contribution of aldehyde oxidase to metabolic clearance. Drug Metab. Dispos. 40:1441-1448.
Zientek, M., Jiang, Y., Youdim, K., and Obach, R.S. 2010. In vitro-in vivo correlation for intrinsic clearance for drugs metabolized by human aldehyde oxidase. Drug Metab. Dispos. 38:1322- 1327
- There are currently no refbacks.